Dental anesthesiology falls short of becoming ADA specialty
Dental anesthesiology came close to becoming the 10th ADA recognized specialty but fell short last week when a majority of the House of Delegates (HOD)
Dental anesthesiology came close to becoming the 10th ADA recognized specialty but fell short last week when a majority of the House of Delegates (HOD)
A new study comparing the effectiveness of propofol-remifentanil and propofol-ketamine combinations for the removal of all four third molars found that the latter is a
Accutron has voluntarily recalled the Ultra PC% cabinet-mount flow meter, used with nitrous oxide-oxygen sedation systems. The company issued the recall after learning through customer
A Coalinga, CA, dentist whose developmentally disabled son died after the dentist gave him Valium and morphine before treating an abscessed tooth has been ordered
Advocates for dental anesthesiology have embarked on the difficult process of getting it approved as the 10th ADA-recognized specialty. After a May 4 vote by
Milestone Scientific saw an 8% decrease in sales for the second quarter of 2012 (end-June 30, 2012) to $2.3 million from $2.5 million for the
In the latest edition of its Critical Summaries series, the Journal of the American Dental Association (JADA) spotlights a study touting superiority of articaine over
While the use of propofol and remifentanil are increasing in orthognathic surgery, patients may experience more postoperative pain than with other types of anesthesia, according
A Coalinga, CA, dentist whose developmentally disabled son died after the dentist gave him Valium and morphine before treating an abscessed tooth will not serve
The Healthcare Supply Chain Association (HSCA) is applauding U.S. Congress’ passage of the Food and Drug Administration Safety and Innovation Act (S. 3187), which is
The company Medical Marijuana has acquired a 50% stake in CanChew, a cannabinoid (CBD)-based chewing gum developed as a pharmaceutical delivery mechanism to relieve pain,
Pharmaceutical Associates, a South Carolina-based drug manufacturer, has discontinued production of chloral hydrate oral solution, an anesthetic used in pediatric dentistry. The company cited “business